FDA panel endorses first-of-a-kind cancer blood test from Grail

Дата публикации: 23-09-2026 23:10:29

WASHINGTON (AP) — Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works. Grail Inc.’s Galleri test doesn't diagnose cancer but instead, with a single blood draw, looks for a signal that someone [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA panel endorses first-of-a-kind cancer blood test from Grail	0	8.41	23-09-2026
2	FDA panel endorses first-of-a-kind cancer blood test from Grail	0	8.41	23-09-2026
3	В Москве представили инновационный тест для раннего обнаружения рака	0	0	02-10-2025
4	Blood test shows promise for detecting pancreatic cancer at its earliest stages	0	5.07	16-09-2026
5	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
6	New blood test shows superior sensitivity in detecting HPV-associated head and neck cancers	7	8	20-05-2025
7	<![CDATA[FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test]]>	0	12.66	14-10-2026
8	В России разработали ПЦР-тест для оценки агрессивности рака	5	7	02-07-2026
9	Онколог Мочалова рассказала о методе обнаружения рака на «нулевой» стадии	0	7.66	28-07-2026
10	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.41. Источник: www.8newsnow.com.